Cargando…

BCL7C suppresses ovarian cancer growth by inactivating mutant p53

B-cell CLL/lymphoma 7 protein family member C (BCL7C) located at chromosome 16p11.2 shares partial sequence homology with the other two family members, BCL7A and BCL7B. Its role in cancer remains completely unknown. Here, we report our finding of its tumor-suppressive role in ovarian cancer. Support...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Canhua, Hao, Qian, Shi, Getao, Zhou, Xiang, Zhang, Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104935/ https://www.ncbi.nlm.nih.gov/pubmed/33306126 http://dx.doi.org/10.1093/jmcb/mjaa065

Ejemplares similares

Ubiquitin ligase TRIM71 suppresses ovarian tumorigenesis by degrading mutant p53
por: Chen, Yajie, et al.
Publicado: (2019)

CKAP4 and mutant p53 cooperatively abrogate cell cycle checkpoint to induce genotoxic resistance in ovarian cancer
por: Huang, Canhua, et al.
Publicado: (2023)

Suppression of the Proliferation of Huh7 Hepatoma Cells Involving the Downregulation of Mutant p53 Protein and Inactivation of the STAT 3 Pathway with Ailanthoidol
por: Tseng, Tsui-Hwa, et al.
Publicado: (2022)

Ubiquitin ligase DTX3 empowers mutant p53 to promote ovarian cancer development
por: Wang, Shanshan, et al.
Publicado: (2020)

Mutant p53 in cancer therapy—the barrier or the path
por: Zhou, Xiang, et al.
Publicado: (2018)

Induction of Ovarian Leiomyosarcomas in Mice by Conditional Inactivation of Brca1 and p53
por: Quinn, Bridget A., et al.
Publicado: (2009)

Cancer-derived p53 mutants suppress p53-target gene expression—potential mechanism for gain of function of mutant p53
por: Vikhanskaya, Faina, et al.
Publicado: (2007)

Heterozygous inactivation of tsc2 enhances tumorigenesis in p53 mutant zebrafish
por: Kim, Seok-Hyung, et al.
Publicado: (2013)

Trans-splicing repair of mutant p53 suppresses the growth of hepatocellular carcinoma cells in vitro and in vivo
por: He, Xingxing, et al.
Publicado: (2015)

Targeting Oncogenic Mutant p53 and BCL-2 for Small Cell Lung Cancer Treatment
por: Neely, Victoria, et al.
Publicado: (2023)

Editor's Note on ‘Cancer-derived p53 mutants suppress p53-target gene expression—potential mechanism for gain of function of mutant p53’
Publicado: (2023)

USP7 inactivation suppresses APC-mutant intestinal hyperproliferation and tumor development
por: Novellasdemunt, Laura, et al.
Publicado: (2023)

Suppression of gain-of-function mutant p53 with metabolic inhibitors reduces tumor growth in vivo
por: Jung, Chae Lim, et al.
Publicado: (2016)

Structures of p53/BCL-2 complex suggest a mechanism for p53 to antagonize BCL-2 activity
por: Wei, Hudie, et al.
Publicado: (2023)

Epigenetic silencing of BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FU
por: Li, Xin, et al.
Publicado: (2015)

Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer
por: Hofstetter, G, et al.
Publicado: (2011)

Inactivation of the tumor suppressor p53 by long noncoding RNA RMRP
por: Chen, Yajie, et al.
Publicado: (2021)

Role of Reactivating Mutant p53 Protein in Suppressing Growth and Metastasis of Triple-Negative Breast Cancer
por: Berke, Taylor P, et al.
Publicado: (2022)

Homoharringtonine suppresses imatinib resistance via the Bcl-6/p53 pathway in chronic myeloid leukemia cell lines
por: Wang, Qian, et al.
Publicado: (2017)

Stathmin regulates mutant p53 stability and transcriptional activity in ovarian cancer
por: Sonego, Maura, et al.
Publicado: (2014)

Stathmin regulates mutant p53 stability and transcriptional activity in ovarian cancer
por: Sonego, Maura, et al.
Publicado: (2013)

P53 Gain-of-Function Mutants and Steroids in Ovarian Cancer Cell Metastasis
por: Candelaria, Nicholes, et al.
Publicado: (2021)

FBXW7 inactivation induces cellular senescence via accumulation of p53
por: Gong, Longyuan, et al.
Publicado: (2022)

Inactivation of wild-type p53 by a dominant negative mutant renders MCF-7 cells resistant to tubulin-binding agent cytotoxicity
por: Galmarini, C M, et al.
Publicado: (2001)

A novel mutant p53 binding partner BAG5 stabilizes mutant p53 and promotes mutant p53 GOFs in tumorigenesis
por: Yue, Xuetian, et al.
Publicado: (2016)

AXL Inactivation Inhibits Mesothelioma Growth and Migration via Regulation of p53 Expression
por: Song, Wei, et al.
Publicado: (2020)

Mutant P53 induces MELK expression by release of wild-type P53-dependent suppression of FOXM1
por: Bollu, Lakshmi Reddy, et al.
Publicado: (2020)

Mutant p53-R273H mediates cancer cell survival and anoikis resistance through AKT-dependent suppression of BCL2-modifying factor (BMF)
por: Tan, B S, et al.
Publicado: (2015)

BCL11B suppresses tumor progression and stem cell traits in hepatocellular carcinoma by restoring p53 signaling activity
por: Yang, Wen-Jing, et al.
Publicado: (2020)

Plakoglobin Reduces the in vitro Growth, Migration and Invasion of Ovarian Cancer Cells Expressing N-Cadherin and Mutant p53
por: Alaee, Mahsa, et al.
Publicado: (2016)

p53’s Extended Reach: The Mutant p53 Secretome
por: Pavlakis, Evangelos, et al.
Publicado: (2020)

Mutant p53 Drives Cancer by Subverting Multiple Tumor Suppression Pathways
por: Haupt, Sue, et al.
Publicado: (2016)

The gut microbiome switches mutant p53 from tumour-suppressive to oncogenic
por: Kadosh, Eliran, et al.
Publicado: (2020)

PGPIPN, a Therapeutic Hexapeptide, Suppressed Human Ovarian Cancer Growth by Targeting BCL2
por: Wang, Wei, et al.
Publicado: (2013)

Mitochondrially targeted p53 or DBD subdomain is superior to wild type p53 in ovarian cancer cells even with strong dominant negative mutant p53
por: Lu, Phong, et al.
Publicado: (2019)

Expression of Galectin-7 Is Induced in Breast Cancer Cells by Mutant p53
por: Campion, Carole G., et al.
Publicado: (2013)

CDC20 regulates the cell proliferation and radiosensitivity of P53 mutant HCC cells through the Bcl-2/Bax pathway
por: Zhao, Shuai, et al.
Publicado: (2021)

HPV infection and p53 inactivation in pterygium
por: Tsai, Yi-Yu, et al.
Publicado: (2009)

Expression of bcl-2 and p53 in bovine cutaneous fibropapillomas
por: Bocaneti, Florentina, et al.
Publicado: (2015)

Gender, mutant p53 and PML: A growing “affaire” in tumor suppression and oncogenesis
por: Di Agostino, Silvia, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_3b3km7oq5iv9h0n058jciicemp